Archive
Maze meets own expectations in Phase 2 kidney disease trial in the same arena as Vertex
Vertex reports Phase 3 win for kidney drug, will seek FDA approval
Vertex races to FDA after phase 3 kidney disease data impress analysts
Vertex kidney disease drug hits mark in late-stage study
Vertex’s CRISPR therapy rebounds in latest earnings
Immunic's private placement; Vertex's cystic fibrosis data in young kids
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex
AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations
Vertex CRISPR therapy hits early goal in children with blood disorders
Directory
59 All
Thermo Fisher
News Danaher
News Agilent
News Merck KGaA
News Illumina
News Waters
News Bruker
News Sartorius
News Mettler Toledo
News PerkinElmer (Revvity)
News Bio-Rad
News Carl Zeiss
News Nikon
News Eppendorf
News Corning
News BD (Becton Dickinson)
News Qiagen
News MGI Tech (华大智造)
News Haier Biomedical
News Lonza
News WuXi AppTec (药明康德)
News WuXi Biologics
News Charles River
News Catalent
News Samsung Biologics
News IQVIA
News LabCorp
News Eurofins
News Pharmaron (康龙化成)
News Pfizer
News Roche
News Merck & Co. (MSD)
News Novartis
News Eli Lilly
News Novo Nordisk
News Moderna
News BioNTech
News Amgen
News BeiGene (百济神州)
News Vertex
News Schrödinger
News Recursion
News Exscientia
News Insilico Medicine
News XtalPi (晶泰科技)
News NVIDIA Healthcare
News DeepMind (Google)
News Medtronic
News Siemens Healthineers
News GE HealthCare
News Philips
News Abbott
News Intuitive Surgical
News Boston Scientific
News Edwards Lifesciences
News Mindray (迈瑞)
News United Imaging (联影)
News Sysmex
News Hologic
News